also places a premium on collaborating with clients from the earliest stages. For example, when approached by a client with a bispecific or fusion protein with multiple binding sites, Sword Bio held detailed client discussions to generate an assay for the therapeutic, rather than trying to execute with standard assay protocols. Taking the opportunity to prompt scientific discussions early in the process helped Sword Bio get the project completed quickly and correctly the first time. This approach is facilitated by Sword Bio’s team of industry experts, who have been well-equipped with the necessary tools and knowledge to uphold the company’s stringent processes. Sword Bio fosters a client-focused culture and seeks out team members who truly believe in the company’s goals, which are to support its clients however it can in getting their drug to the market as fast as possible. “We want to make sure we are known as the number one service provider in our industry, and that means always going above and beyond for our clients,” David says. “At the end of the day, we are in the life saving business, and we want team members that understand both the opportunity and responsibility we have.” Being based in Chicago has certainly aided this mission, as the lab is easily accessible with a nonstop flight from anywhere in the country as well as 46 countries around the world, making client visits easy. It has also made it easier for Sword Bio to attract top talent, as the city has so much to offer while having a lower cost of living than many other hubs. Moving forward, David tells us that Sword Bio will be focused on delivering a premium service that goes above and beyond the standards of our industry. “Thankfully, our leadership team has experience building companies while embracing our core values. By hiring ahead of the curve and with a team that shares common goals, we are confident that we will be able to grow while delivering the same service, science, and quality we are known for.” Contact: David Osband Email: [email protected] Company: Sword Bio, Inc. Web Address: https://swordbio.com/ 11 GHP Q4 2024 Serving pharma and biotech customers since 2017, and with a team of top experts from the CRO industry, Sword Bio has the experience and expertise in supporting bioanalysis for discovery, preclinical, and clinical trials. With a core focus on ADA, PK, Nab methods and Biomarker services, Sword Bio has built an innovative process that offers its customers immediate project start times, no project minimums, transparency, an emphasis on communication, and true white-glove service that enables clients to quickly achieve their goals. Over the years, Sword Bio has curated a team of industry experts wanting to work for a company that places its focus solely on service, science, and quality. This team is comprised of industry-leading science and QA experts who ensure that the highest levels of science, data integrity, and regulatory compliance throughout all phases of drug development. Sword Bio strives to provide an exceptional white-glove service to its sponsors. Before a contract is signed, our subject matter experts meet with potential clients to understand the project goals, timelines and regulatory requirements. We meet free of charge and as many times as needed to put together an SOW tailored to their needs. Once an SOW is signed, sponsors are assigned a Principal Investigator, or PI, and a dedicated team trained to directly communicate with the sponsor and effectively track all study activities throughout the project, which includes the science, timelines, and budgetary elements. This same scientific team develops and validates the method and completes the sample analysis without being transferred to different teams, as is often the case at many CRO’s. To guarantee that this process is as streamlined as possible, Sword Bio does predictive hiring to ensure that it has trained resources that enable the company to begin working on clients’ projects immediately, another industry best in class process. In many cases customers can wait months for their project to start. While this may be a more expensive approach for Sword Bio, it ensures that projects are quickly staffed and drugs get to the market much sooner, which is an important client need that is worth the cost. “Our priority is to offer our clients a CRO that is focused on delivering the best service and science they have come across” David tells us. “We prove this by having dedicated teams, rapid response times, only “A” players and a culture built on making sure every client feels like they are our most important client. We want to be there for our clients for all their needs, big or small.” In such a fast-advancing industry as biotechnology research, it is crucial to remain ahead of the market. To remain competitive, Sword Bio not only maintains its expertise in this ever-changing market but Based in Chicago, Sword Bio is a leading bioanalytical CRO that supports biotech and pharmaceutical companies for their discovery, preclinical and clinical method development, validation, and sample analysis needs within its GLP and GCP compliant laboratory. Capable of responding to the industry’s evolving needs, from assay development to clinical testing, Sword Bio has been recognized for its excellence in the International Life Sciences Awards 2024. Below, we speak with David Osband, Executive Vice President of Sales and Marketing at Sword Bio. Most Innovative Collaborative Bioanalytical Lab 2024 – USA
RkJQdWJsaXNoZXIy NTY1MjM3